Abstract
Quantitative imaging modalities are promising methods for improving lung cancer identification and follow-up, as they use more accurate parameters than subjective analyses for assessment and prediction of treatment response, thus optimizing care for individual patients. Although magnetic resonance imaging (MRI) is used for clinical indication of lung cancer, various limitations have hampered the clinical application of this technique for thoracic and lung diseases. It has recently been suggested that advancements in MRI, such as dynamic first-pass contrast-enhanced (CE)-perfusion MRI, diffusion-weighted imaging (DWI), or chemical exchange saturation transfer (CEST) imaging, can be effective for nodule assessment, tumor staging, and therapeutic effect prediction or evaluation in routine clinical practice or academic studies. This chapter deals with the basics of perfusion imaging, DWI, and CEST imaging as well as clinical applications of quantitative assessment using these three MR methods for patients with pulmonary nodules, masses, or lung cancer.
| Original language | English |
|---|---|
| Title of host publication | Quantitative Imaging in the Thorax |
| Publisher | Springer Nature |
| Pages | 351-375 |
| Number of pages | 25 |
| ISBN (Electronic) | 9783032141033 |
| ISBN (Print) | 9783032141026 |
| DOIs | |
| Publication status | Published - 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
- General Computer Science
Fingerprint
Dive into the research topics of 'Perfusion, Diffusion, and Metabolism of Pulmonary Nodules, Masses, and Lung Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver